Two Sigma Investments’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,364
| Closed | -$41K | – | 2618 |
|
|
2022
Q1 | $41K | Sell |
8,364
-32,776
| -80% | -$161K | ﹤0.01% | 2461 |
|
|
2021
Q4 | $282K | Buy |
41,140
+33,931
| +471% | +$233K | ﹤0.01% | 2182 |
|
|
2021
Q3 | $222K | Buy |
7,209
+2,108
| +41% | +$64.9K | ﹤0.01% | 2283 |
|
|
2021
Q2 | $166K | Sell |
5,101
-23,508
| -82% | -$765K | ﹤0.01% | 2256 |
|
|
2021
Q1 | $1.08M | Sell |
28,609
-14,583
| -34% | -$551K | ﹤0.01% | 1555 |
|
|
2020
Q4 | $2.04M | Sell |
43,192
-3,312
| -7% | -$157K | 0.01% | 1063 |
|
|
2020
Q3 | $1.5M | Buy |
46,504
+4,008
| +9% | +$129K | 0.01% | 1026 |
|
|
2020
Q2 | $1.87M | Buy |
42,496
+14,855
| +54% | +$654K | 0.01% | 900 |
|
|
2020
Q1 | $906K | Sell |
27,641
-2,737
| -9% | -$89.7K | 0.01% | 994 |
|
|
2019
Q4 | $1.55M | Buy |
30,378
+16,647
| +121% | +$850K | ﹤0.01% | 1220 |
|
|
2019
Q3 | $506K | Sell |
13,731
-620
| -4% | -$22.8K | ﹤0.01% | 1452 |
|
|
2019
Q2 | $793K | Buy |
14,351
+1,169
| +9% | +$64.6K | ﹤0.01% | 1441 |
|
|
2019
Q1 | $802K | Buy |
13,182
+5,487
| +71% | +$334K | ﹤0.01% | 1501 |
|
|
2018
Q4 | $455K | Sell |
7,695
-18,418
| -71% | -$1.09M | ﹤0.01% | 1610 |
|
|
2018
Q3 | $2.11M | Buy |
26,113
+19,300
| +283% | +$1.56M | 0.01% | 1078 |
|
|
2018
Q2 | $596K | Buy |
6,813
+4,401
| +182% | +$385K | ﹤0.01% | 1576 |
|
|
2018
Q1 | $467K | Buy |
+2,412
| New | +$467K | ﹤0.01% | 1592 |
|
|
2015
Q1 | – | Sell |
-174
| Closed | -$361K | – | 2212 |
|
|
2014
Q4 | $361K | Buy |
174
+63
| +57% | +$131K | ﹤0.01% | 1862 |
|
|
2014
Q3 | $222K | Buy |
111
+7
| +7% | +$14K | ﹤0.01% | 1572 |
|
|
2014
Q2 | $371K | Buy |
104
+23
| +28% | +$82K | ﹤0.01% | 1749 |
|
|
2014
Q1 | $302K | Sell |
81
-67
| -45% | -$250K | ﹤0.01% | 1677 |
|
|
2013
Q4 | $484K | Sell |
148
-81
| -35% | -$265K | ﹤0.01% | 1675 |
|
|
2013
Q3 | $958K | Buy |
229
+38
| +20% | +$159K | 0.01% | 1033 |
|
|
2013
Q2 | $642K | Buy |
+191
| New | +$642K | ﹤0.01% | 1290 |
|